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an improved vaccine against PRRS. 
INTRODUCTION
An animal experiment was conducted by inoculating 3-week-old PRRSV-negative piglets 145 with the rA2MC2 virus. The pigs were euthanized at 14 days post-infection (DPI). Compared 146 with the pigs inoculated with parental A2MC2 virus, the pigs infected with the rA2MC2 virus 147 had similar lesion scores, though there were some low responders (Fig. 4a) . 148 Real-time PCR was conducted to determine PRRSV RNA in serum samples of 14 DPI. 149 The average PRRSV RNA levels for the pigs infected with the rA2MC2 and the parental A2MC2 150 virus were 4.55 and 4.46 log 10 copies/ml, respectively (Fig. 4b ). There was no significant 151 difference in the PRRSV RNA levels between the two groups. These results suggest that the 152 rA2MC2 virus has similar virulence and replication kinetics in pigs compared to its parental 153 A2MC2 virus.
154
Construction of chimeric cDNA infectious clones and determination of the growth property 155 of the recovered chimeric virus 156 To determine the genetic source of A2MC2 virus for interferon induction, we constructed 157 three chimeric A2MC2 infectious clones by genomic fragment swapping with pIR-VR2385 ( Fig.   158 5a). VR-2385 does not induce IFNs [18] and the pIR-VR2385 was robust in virus recovery [23] . 159 The cDNA sequence of the viral genome in pIR-VR2385 is shorter than the A2MC2 sequence 160 due to deletion in nsp2 [23] . So the nucleotide positions of the three restriction enzymes are 161 different from A2MC2 cDNA (Fig. 5a ). The F2, F3, and F1-F3 fragments in pIR-VR2385 were 162 replaced with their counterparts of A2MC2, resulting in chimeric clones: pIR-VR2385/A2F2, 163 pIR-VR2385/A2F3, and pIR-VR2385/A2F123. MARC-145 cells were transfected with these 164 chimeric infectious clones as well as pIR-VR2385 and pIR-A2MC2 plasmids for virus recovery 165 separately. The virus recovery was successful from all the clones. The chimeric viruses were subjected to growth property assay in MARC-145 cells. The 167 virus yields for the cells inoculated with the rA2F2 and rVR2385 from 48 to 96 hpi were similar 168 (Fig. 5b) . The virus yields for the cells inoculated with the rA2MC2 and rA2F3 were similar, 169 approximately 0.5-1 log lower than rA2F2 and rVR2385 at 72 and 96 hpi. All the viruses had 170 similar yields at 48 hpi. The yields for the rA2F123 virus at 72 and 96 hpi were lower than all the 171 other four viruses. The results indicate that the chimera rA2F2 is similar to rVR2385 in 172 replication rate, chimera rA2F3 is similar to rA2MC2, and chimera rA2F123 has a lower 173 replication rate than both rVR2385 and rA2MC2.
174
A plaque assay was conducted in MARC-145 cells to compare the chimeric viruses. All 175 the chimeric viruses had similar plaque sizes, 2-4 mm in diameter ( Fig. 5c ).
176
The middle half of the strain A2MC2 genome is essential for interferon induction 177 For interferon bioassay, the culture supernatants of MARC-145 cells infected with the 178 chimeric viruses were used to treat Vero cells. Results showed that NDV-GFP replication was 179 inhibited in the Vero cells treated with the culture supernatants of rVR/A2F123 and rA2MC2 180 virus in a dilution up to 1:16 ( Fig. 6a ). However, treatment with the culture supernatants of 181 rVR/A2F2, rVR/A2F3, and rVR2385 viruses had a minimal effect on the NDV-GFP replication 182 when compared to the mock-treated cells. A2MC2 has the same sequence in fragment 1 (nt1-183 4544) as VR-2332, and the latter does not induce IFNs in MARC-145 cells [18] . So both 184 fragments 2 and 3 (nt4545-12709) are critical for the IFN induction.
185
To confirm this observation, immunoblotting to determine the RIG-I protein level in 186 MARC-145 infected with the chimeric viruses was conducted. Compared with the mock-infected 187 cells, the MARC-145 cells infected with rVR/A2F123 chimeric virus at 48 hpi had higher RIG-I 188 protein level, whereas the cells infected with rVR/A2F2 and rVR/A2F3 chimeric viruses had a 189 11 slight reduction (Fig. 6b ). The rVR2385-infected cells had lower RIG-I level than the mock-190 infected cells. This confirmed that the rVR/A2F123 chimeric virus induced interferon production 191 in MARC-145 cells and the presence of both fragments 2 and 3 of the A2MC2 genome is 192 required for the sensing by host pattern recognition receptors. 194 Although it has been nearly 30 years since the first reports of PRRS, broadly effective 195 vaccines against PRRSV infection are still not available due to the genetic diversity of PRRSV 196 isolates and apparent lack of cross-protection between isolates [2]. It is known that PRRSV 197 strains generally antagonize interferon synthesis [14, 18, 24] . The effect of PRRSV replication 198 on IFN induction appears to be variable among different strains and different cell types. PRRSV The interferon induction by PRRSV strain A2MC2 is a unique feature of this virus. Considering 201 the importance of interferons in activating the adaptive immune response [11, 25] , this feature is 202 desirable in vaccine development against PRRSV. Type I IFNs have an important role in the 203 differentiation of CD4 + and CD8 + T cells [11, 25] . This study identified that the middle half of 204 the A2MC2 genome is pivotal for IFN induction by chimeric infectious clone analyses. The 205 rescued A2MC2 virus has the capability of IFN induction in cultured cells like its parental strain.
193

DISCUSSION
206
Treatment of Vero cells with the culture supernatants from rA2MC2-infected cells induced 207 expression of ISG15, RIG-I, and STAT2, which indicates the activation of IFN signaling. The 208 expression of the interferon-activated genes was confirmed at both the RNA and the protein 209 levels. These results suggest that the genetic feature of A2MC2 is maintained in the cDNA 210 infectious clone.
211
The recovered rA2MC2 virus maintained the feature of IFN induction in cultured cells.
212
The rA2MC2 virus has growth properties in terms of multi-step growth and plaque formation 213 similar to its parental virus. The cells infected with rA2MC2 inoculum at an MOI of 0.01 had 214 higher viral yields than the cells inoculated with an MOI of 0.1 and 1.0, which indicates less 215 inoculum leads to more efficient virus replication. This result is also consistent with the feature 216 13 of IFN induction. The lower the inoculum, the less IFN induction in the cells and the weaker the 217 antiviral response the cells would mount. The virus in the cells at low level would have a better 218 chance to replicate to high level without triggering a rigorous antiviral response than high level 219 of virus in the initial inoculum.
220
The rA2MC2 virus led to pathology and viremia in pigs similar to its parental virus, 221 though the lung lesion scores were numerically variable among the pigs infected. This is possible 222 due to the variation of individual pigs used in this study, some of which were low responders. 223 This is also indicated by their similar viremia levels. The rA2MC2 virions are expected to be a 224 more homogenous population than the wild type virus though the latter was plaque purified [18] .
225
The chimeric cDNA clones of A2MC2 and VR-2385 were constructed. Similar growth 226 trend and yields from 48 to 96 hpi were observed between the rA2F2 and rVR2385, as well as 227 between the rA2F3 and rA2MC2. All the five recovered viruses have similar yields at 48 hpi.
228
The rA2F123 has similar yields to rVR2385, but lower yields than the other four viruses at 72 229 and 96 hpi, which may be because rA2F123 induces IFNs. The yields of the rA2MC2 virus was 230 slightly higher than rA2F123 in the two late time points when the cells were inoculated at this 231 amount of inoculum. It is not known whether the fragment 4 that are different between these two 232 recovered IFN-inducing viruses contributes to the variation in late virus replication.
233
The chimeric clones of A2MC2 and VR-2385 were used to study the genomic source of 234 the IFN induction. Since the nucleotide sequence of A2MC2 fragment 1 (nt1-4544) is the same 235 as VR-2332 and the latter antagonizes IFN induction [18], the fragment 1 has no pivotal role in 236 the A2MC2 induction of IFNs. Thus, the genomic source for the IFN induction must be from the in the A2MC2 genome encodes proteins of C-terminal 126 amino acid residues of nsp2, nsps 3-240 12, and N-terminal 213 residues of GP2a. Among these PRRSV nsps, nsp2, nsp4, and nsp11 are 241 reported to inhibit IFN induction [14, 26] . A2MC2 has the identical nsp2, nsp4, and nsp11 as 242 VR-2332 or MLV [18] . Thus, lack of inhibition of IFN induction by these proteins is not 243 possible.
244
Our results indicate that the middle half genome of A2MC2 contributes to the PAMP 245 recognition by host PRR. RIG-I and MDA5 are the PRR to sense viral RNA in the cytoplasm. This is consistent with our observation that A2MC2 replication is needed for the IFN induction 254 as UV-inactivated A2MC2 virus cannot trigger IFNs [18] . We speculate that many PRRSV 255 strains like VR-2332 and VR-2385 that antagonize IFN induction may escape the MDA5 256 recognition by formation of a different internal duplex structure.
257
Our data indicate that both fragments 2 and 3 (nt4545 to nt12709) of A2MC2 are pivotal 258 for the possible internal duplex structure for MDA5 recognition. Replacement of either F2 or F3 . Our data indicates that A2MC2 has a unique mechanism to trigger IFN synthesis, 280 which is presumed to begin before the nsps are able to mount sensible suppression. This 281 presumption is in consistent with our result that replication kinetics of A2MC2 is inverse 282 proportional to the inoculum MOI. This mechanism is stable during serial passaging for 90 times 283 in cultured cells since the A2MC2-P90 maintains the feature of IFN induction [22] .
284
In conclusion, the middle half genome of strain A2MC2 is pivotal for its IFN induction.
16
The DNA-launched cDNA infectious clone of A2MC2 was constructed, and the recovered virus 286 carries the unique feature of interferon induction in cultured cells. Further study using the 287 A2MC2 cDNA infectious clone is warranted for examination of the precise mechanism of IFN 288 induction and development of an improved vaccine against PRRS. 
289
MATERIALS AND METHODS
Construction of cDNA clone of PRRSV strain A2MC2
309
The strategy to construct the cDNA clone of A2MC2 (passage 10) is illustrated in Fig. 1a Inc., Madison, WI). The GenBank accession number of the cDNA sequence of A2MC2 genomic 358 RNA is JQ087873.
359
Animal study 360 The animal study was approved by the Institutional Animal Care and Use Committees 361 (IACUC) of Iowa State University and the University of Maryland and according to relevant 362 guidelines and policies for the care and use of laboratory animals. Three-week-old PRRSV-363 negative piglets were randomly divided into three groups with 4 pigs in each group. The piglets 364 in groups 1 and 2 were inoculated with 1 ml of wild type A2MC2 (passage 10) and rA2MC2 365 (passage 6), respectively, at 10 5 TCID 50 /ml via intranasal inoculation (I.N.), while group 3 was 366 mock-infected with phosphate-buffered saline (PBS) pH7.2. The pigs were observed daily.
367
Blood samples were collected prior to inoculation and at 14-day post-infection (DPI).
368
The pigs were euthanized on DPI14 by pentobarbital overdose (FATAL-PLUS, Vortech 369 Pharmaceuticals, LTD. Dearborn, MI). Visible macroscopic lung lesions were scored and 370 recorded as previously described [45, 46] .
371
Statistical analysis 372
Differences between treatment and control samples were assessed by the t-test Whitney test (nonparametric)) in GraphPad Prism. A two-tailed P-value of less than 0.05 was 374 considered statistically significant. The bars in the images correspond to 10 mm. 
